Back

Human Gut Bacteria Convert Endogenous Steroids into Host Cortisol Shuttle Inhibitors

Moser, S. O.; Walsh, J. T.; Spane, P. M.; Harkonen, T.; Lalli, M.; Zalosnik, I.; Winter, D. V.; Park, J.; Magicheva-Gupta, M.; McCurry, M. D.; Morris, D. J.; Bang, Y.-J.; Huh, J. R.; Labelle, P. A.; Chan, A. T.; Drew, D. A.; Song, M.; Lewis, J. D.; Wu, G. D.; Bisanz, J. E.; Vatanen, T.; van Diest, R. E.; Knip, M.; Odermatt, A.; Devlin, A. S.

2026-08-22 microbiology
10.64898/2026.08.21.746344 bioRxiv
Show abstract

11{beta}-hydroxysteroid dehydrogenase 2 (HSD11B2) protects the mineralocorticoid receptor from glucocorticoid overstimulation by inactivating cortisol. HSD11B2 inhibition can drive receptor overactivation and contribute to hypertension; however, endogenous inhibitors remain poorly defined. Glycyrrhetinic acid-like factors (GALFs) are steroid-like metabolites that inhibit HSD11B2. Given the capacity of gut bacteria to metabolize host steroids, we hypothesized that the gut microbiome could generate GALF-like inhibitors. Here, we identify two 11-oxygenated steroid metabolites that potently inhibit human HSD11B2 in colonic cells and organoids, enabling cortisol-dependent mineralocorticoid receptor activation. We identify gut bacteria and enzymes that produce these compounds and show that their levels are markedly reduced in antibiotic-treated humans. One metabolite is elevated during pregnancy, and both are higher in individuals with stage 2 hypertension-range blood pressure. These findings reveal a bacterial route to altered host cortisol signaling and suggest a potential link between microbiome-derived GALFs and blood pressure regulation.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.